BPA Call 36C24222A0007-36C24226N0309
- Not listed
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, received a $100,000 Blanket Purchase Agreement (BPA) call for chemotherapy compounding services from Veterans Integrated Service Network 2 (VISN 2) on November 17, 2025. The contract, which is classified as Firm Fixed Price with no set-aside designation, will support the Department of Veterans Affairs' oncology and infusion treatment programs through specialized pharmaceutical compounding services. The performance...
- This is a federal contract award for CHEMOTHERAPY COMPOUND SERVICE, awarded by the Veterans Integrated Service Network 2 (VISN 2) to the prime contractor Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, and has a ceiling value of $19,603.80. The contract has an ultimate completion date of November 16, 2026, and was awarded on November 20, 2025. The place of performance is...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, was awarded a $100,000 delivery order under the Compounded Chemotherapy Indefinite Delivery/Quantity (IDIQ) contract by Veterans Integrated Service Network 22 (VISN 22) on October 1, 2025. This firm fixed-price delivery order, with a completion date of September 30, 2026, will be performed in Phoenix, Arizona. The contract covers specialized pharmaceutical compounding services, specifically the preparation of customized...
- This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract is for a Blanket Purchase Agreement (BPA) call to provide chemotherapy compound JJP at a firm-fixed price of $20,583.99. The award has an ultimate completion date of November 16, 2026. This contract is not set aside and was awarded through full and open competition. Optum Pharmacy 801, Inc. is a...
- This federal contract award, valued at $74,885.03, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract is a firm fixed-price purchase order for the "Ratification of Two UACs", with an ultimate completion date of November 30, 2024. Optum Pharmacy 801, Inc. is a specialized pharmacy that provides compounded chemotherapy agents, hazardous...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract is for $84,822.20 and provides chemotherapy compound drug hood services. The contract has an ultimate completion date of November 19, 2025. Optum Pharmacy 601, LLC is a for-profit limited liability company that specializes in providing...
- The federal contract award with ID 36C24221A0010|36C24224N0317 was issued by the Veterans Integrated Service Network 2 (VISN 2), a component of the U.S. Department of Veterans Affairs (VA), to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The $21,490.22 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) call for chemotherapy compound drug hood services, with a period of performance through November 19, 2024. Optum Pharmacy 601 is an established government...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $150,000 Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc. for pharmacy compounding services with a three-month extension period concluding on February 28, 2026. This firm fixed-price contract, awarded on December 1, 2025, represents a task order issued under an existing $8 million BPA for hazardous pharmacy compounding services. The work will be performed in Wichita, Kansas,...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, was awarded a $400,000 firm fixed-price delivery order by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 (VISN 20) for pharmacy compounding services. The delivery order, which commenced on December 1, 2025, and is scheduled for completion by November 30, 2026, will be performed at the contractor's facility in Chandler, Arizona. This contract was awarded through full and open competition...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a delivery order valued at $1.35M to Optum Pharmacy 801, Inc. for hazardous pharmaceutical compounding services. The contract, which commenced on October 1, 2024, and extends through September 30, 2029, was awarded on a firm fixed-price basis without set-aside designation through full and open competition. The work will be performed in Biloxi, Mississippi, and involves the preparation of...
- 36C24222A0007Blanket Purchase Agreement
- 36C24222A0007-36C24226N0309BPA Call
The Veterans Integrated Service Network 2 (VISN 2) awarded a Blanket Purchase Agreement (BPA) call valued at $19,603.80 to Optum Pharmacy 801, Inc. on November 20, 2025, for the supply of chemotherapy compound for use within the Veterans Health Administration. This firm fixed-price contract will be performed in Phoenix, Arizona, and is scheduled for completion by November 16, 2026. The award was made without a set-aside designation through a competitive procurement process. Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, specializes in advanced pharmaceutical compounding services for the Department of Veterans Affairs, including the preparation of chemotherapy agents, hazardous sterile preparations, and patient-specific intravenous medications. The contractor operates as a 503A certified pharmacy and has established a track record of delivering complex pharmaceutical compounding services across multiple VA VISNs. This BPA call represents a task order issued under a larger blanket purchase agreement framework, enabling the VA to procure critical pharmaceutical compounding services on an as-needed basis to support oncology and infusion treatment programs for veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 12/31/25 |